Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$0.97 - $1.7 $11,674 - $20,461
-12,036 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.9 - $1.95 $10,832 - $23,470
12,036 New
12,036 $13,000
Q2 2019

Aug 14, 2019

SELL
$0.96 - $1.89 $68,343 - $134,550
-71,191 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$1.76 - $3.73 $31,646 - $67,069
17,981 Added 33.79%
71,191 $126,000
Q4 2018

Feb 14, 2019

BUY
$2.01 - $4.21 $106,952 - $224,014
53,210 New
53,210 $196,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.